0967-3849 < 0968-0896 < 0968-4328

Facettes : Author.f AffPays.f AffRegion.f AffVille.f AffOrg.f KwdFr.f Mesh.f MeshFr.f Teeft.f

List of bibliographic references indexed by 0968-0896

Number of relevant bibliographic references: 31.
[0-20] [0 - 20][0 - 31][20-30][20-40]

Ident.	Authors (with country if any)	Title
001053 (2016)	Hiroyuki Konno [Japon] ; Masaki Wakabayashi [Japon] ; Daiki Takanuma [Japon] ; Yota Saito [Japon] ; Kenichi Akaji [Japon]	Design and synthesis of a series of serine derivatives as small molecule inhibitors of the SARS coronavirus 3CL protease
001227 (2015)	Sarah E. St. John [États-Unis] ; Sakshi Tomar [États-Unis] ; Shaun R. Stauffer [États-Unis] ; Andrew D. Mesecar [États-Unis]	Targeting zoonotic viruses: Structure-based inhibition of the 3C-like protease from bat coronavirus HKU4—The likely reservoir host to the human coronavirus that causes Middle East Respiratory Syndrome (MERS)
001647 (2014)	Yasuhiro Shimamoto [Japon] ; Yasunao Hattori [Japon] ; Kazuya Kobayashi [Japon] ; Kenta Teruya [Japon] ; Akira Sanjoh [Japon] ; Atsushi Nakagawa [Japon] ; Eiki Yamashita [Japon] ; Kenichi Akaji [Japon]	Fused-ring structure of decahydroisoquinolin as a novel scaffold for SARS 3CL protease inhibitors
001847 (2013)	Wei Liu [République populaire de Chine] ; He-Min Zhu [République populaire de Chine] ; Guo-Jun Niu [République populaire de Chine] ; En-Zhi Shi [République populaire de Chine] ; Jie Chen [République populaire de Chine] ; Bo Sun [République populaire de Chine] ; Wei-Qiang Chen [République populaire de Chine] ; Hong-Gang Zhou [République populaire de Chine] ; Cheng Yang [République populaire de Chine]	Synthesis, modification and docking studies of 5-sulfonyl isatin derivatives as SARS-CoV 3C-like protease inhibitors
001921 (2013)	Hyun Lee ; Anuradha Mittal ; Kavankumar Patel ; Joseph L. Gatuz ; Lena Truong ; Jaime Torres ; Debbie C. Mulhearn ; Michael E. Johnson	Identification of novel drug scaffolds for inhibition of SARS-CoV 3-Chymotrypsin-like protease using virtual and high-throughput screenings
001F58 (2012)	Ji-Young Park [Corée du Sud] ; JANG HOON KIM [Corée du Sud] ; YOUNG MIN KIM [Corée du Sud] ; HYUNG JAE JEONG [Corée du Sud] ; DAE WOOK KIM [Corée du Sud] ; KI HUN PARK [Corée du Sud] ; Hyung-Jun Kwon [Corée du Sud] ; Su-Jin Park [Corée du Sud] ; WOO SONG LEE [Corée du Sud] ; YOUNG BAE RYU [Corée du Sud]	Tanshinones as selective and slow-binding inhibitors for SARS-CoV cysteine proteases
001F59 (2012)	Li-Jun Wang [République populaire de Chine] ; Chang-An Geng [République populaire de Chine] ; Yun-Bao Ma [République populaire de Chine] ; Xiao-Yan Huang [République populaire de Chine] ; JIE LUO [République populaire de Chine] ; HAO CHEN [République populaire de Chine] ; Rui-Hua Guo [République populaire de Chine] ; Xue-Mei Zhang [République populaire de Chine] ; Ji-Jun Chen [République populaire de Chine]	Synthesis, structure-activity relationships and biological evaluation of caudatin derivatives as novel anti-hepatitis B virus agents
002920 (2010)	Iou-Jiun Kang [Taïwan] ; Li-Wen Wang [Taïwan] ; Teng-Kuang Yeh [Taïwan] ; Chung-Chi Lee [Taïwan] ; Yen-Chun Lee [Taïwan] ; Sheng-Ju Hsu [Taïwan] ; Yen-Shian Wu [Taïwan] ; Jing-Chyi Wang [Taïwan] ; Yu-Sheng Chao [Taïwan] ; Andrew Yueh [Taïwan] ; Jyh-Haur Chern [Taïwan]	Synthesis, activity, and pharmacokinetic properties of a series of conformationally-restricted thiourea analogs as novel hepatitis C virus inhibitors
002921 (2010)	R. Ramajayam [Taïwan] ; Kian-Pin Tan [Taïwan] ; Hun-Ge Liu [Taïwan] ; Po-Huang Liang [Taïwan]	Synthesis and evaluation of pyrazolone compounds as SARS-coronavirus 3C-like protease inhibitors
002948 (2010)	YOUNG BAE RYU [Corée du Sud] ; HYUNG JAE JEONG [Corée du Sud] ; JANG HOON KIM [Corée du Sud] ; YOUNG MIN KIM [Corée du Sud] ; Ji-Young Park [Corée du Sud] ; Doman Kim [Corée du Sud] ; Thi Thanh Hanh Naguyen [Corée du Sud] ; Su-Jin Park [Corée du Sud] ; JONG SUN CHANG [Corée du Sud] ; KI HUN PARK [Corée du Sud] ; Mun-Chual Rho [Corée du Sud] ; WOO SONG LEE [Corée du Sud]	Biflavonoids from Torreya nucifera displaying SARS-CoV 3CLpro inhibition
002951 (2010)	Stefan Mebs [Allemagne] ; Anja Lüth [Allemagne] ; Peter Luger [Allemagne]	A simple procedure for the derivation of electron density based surfaces of drug-receptor complexes from a combination of X-ray data and theoretical calculations
003460 (2008)	Sara Cesarini [Italie] ; Andrea Spallarossa [Italie] ; Angelo Ranise [Italie] ; Paola Fossa [Italie] ; Paolo La Colla [Italie] ; Giuseppina Sanna [Italie] ; Gabriella Collu [Italie] ; Roberta Loddo [Italie]	Thiocarbamates as non-nucleoside HIV-1 reverse transcriptase inhibitors. Part 1. Parallel synthesis, molecular modelling and structure-activity relationship studies on 0-[2-(hetero)arylethyl]-N-phenylthiocarbamates
003467 (2008)	Prasenjit Mukherjee [États-Unis] ; Prashant Desai [États-Unis] ; Larry Ross [États-Unis] ; E. Lucile White [États-Unis] ; Mitchell A. Avery [États-Unis]	Structure-based virtual screening against SARS-3CLpro to identify novel non-peptidic hits
003487 (2008)	CHUNYING NIU [Canada] ; JIANG YIN [Canada] ; JIANMIN ZHANG [Canada] ; John C. Vederas [Canada] ; Michael N. G. James [Canada]	Molecular docking identifies the binding of 3-chloropyridine moieties specifically to the S1 pocket of SARS-CoV Mpro
003500 (2008)	Carly Huitema [Canada] ; JIANMIN ZHANG [Canada] ; JIANG YIN [Canada] ; Michael N. G. James [Canada] ; John C. Vederas [Canada] ; Lindsay D. Eltis [Canada]	Heteroaromatic ester inhibitors of hepatitis A virus 3C proteinase : Evaluation of mode of action
003504 (2008)	Kenichi Akaji [Japon] ; Hiroyuki Konno [Japon] ; Mari Onozuka [Japon] ; Ayumi Makino [Japon] ; Hiroyuki Saito [Japon] ; Kazuto Nosaka [Japon]	Evaluation of peptide-aldehyde inhibitors using R188I mutant of SARS 3CL protease as a proteolysis-resistant mutant
003510 (2008)	Yi-Ming Shao [Taïwan] ; Wen-Bin Yang [Taïwan] ; Tun-Hsun Kuo [Taïwan] ; Keng-Chang Tsai [Taïwan] ; Chun-Hung Lin [Taïwan] ; An-Suei Yang [Taïwan] ; Po-Huang Liang [Taïwan] ; Chi-Huey Wong [Taïwan, États-Unis]	Design, synthesis, and evaluation of trifluoromethyl ketones as inhibitors of SARS-CoV 3CL protease
003B93 (2007)	Masahiro Ikejiri [Japon] ; Takayuki Ohshima [Japon] ; Keizo Kato [Japon] ; Masaaki Toyama [Japon] ; Takayuki Murata [Japon] ; Kunitada Shimotohno [Japon] ; Tokumi Maruyama [Japon]	5'-O-Masked 2'-deoxyadenosine analogues as lead compounds for hepatitis C virus (HCV) therapeutic agents
003C79 (2006)	Xingnan Li [États-Unis] ; Robert Vince	Synthesis and biological evaluation of purine derivatives incorporating metal chelating ligands as HIV integrase inhibitors.
003F68 (2006)	Lili Chen [République populaire de Chine] ; Jian Li ; Cheng Luo ; Hong Liu ; Weijun Xu ; Gang Chen ; Oi Wah Liew ; Weiliang Zhu ; Chum Mok Puah ; Xu Shen ; Hualiang Jiang	Binding interaction of quercetin-3-beta-galactoside and its synthetic derivatives with SARS-CoV 3CL(pro): structure-activity relationship studies reveal salient pharmacophore features.
004411 (2006)	XINGNAN LI [États-Unis] ; Robert Vince [États-Unis]	Synthesis and biological evaluation of purine derivatives incorporating metal chelating ligands as HIV integrase inhibitors

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/ISSN.i -k "0968-0896" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/ISSN.i  \
                -Sk "0968-0896" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    SrasV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    ISSN.i
   |clé=    0968-0896
}}

---

This area was generated with Dilib version V0.6.33. Data generation: Tue Apr 28 14:49:16 2020. Site generation: Sat Mar 27 22:06:49 2021